Marché mondial du traitement des tumeurs du pancréas – Tendances et prévisions de l’industrie jusqu’en 2028

Analyse et perspectives du marché : marché mondial du traitement des tumeurs du pancréas

Le marché du traitement des tumeurs pancréatiques devrait connaître une croissance du marché au cours de la période de prévision 2021-2028. Data Bridge Market Research analyse le marché pour s'attendre à une croissance à un TCAC de 8 % au cours de la période de prévision mentionnée ci-dessus.

La tumeur pancréatique est une tumeur qui se développe dans les cellules du pancréas. Les tumeurs pancréatiques exocrines et les tumeurs neuroendocrines du pancréas sont les deux formes les plus courantes de tumeurs pancréatiques. La majorité des tumeurs malignes du pancréas sont des tumeurs exocrines, qui se développent dans des cellules qui produisent des enzymes pour faciliter la digestion. Les tumeurs neuroendocrines se développent dans les cellules neuroendocrines du pancréas (telles que les cellules des îlots de Langerhans). Ces cellules produisent des hormones qui aident à réguler la glycémie. Les tumeurs neuroendocrines du pancréas peuvent être bénignes (non cancéreuses) ou malignes (cancéreuses) (cancer). Elles sont nettement moins courantes et ont un meilleur pronostic que les tumeurs pancréatiques exocrines.

L'augmentation de la prévalence des tumeurs du pancréas et l'augmentation des dépenses de santé sont les principaux facteurs qui influencent le taux de croissance du marché. En outre, les progrès de la technologie médicale, l'augmentation du financement gouvernemental et les initiatives croissantes des organisations publiques et privées pour faire connaître la maladie et ses options de prévention sont les facteurs qui vont développer le marché du traitement des tumeurs du pancréas. D'autres facteurs, notamment l'incidence croissante du diabète et de l'obésité, la forte consommation de cigarettes et l'augmentation de la population gériatrique, auront un impact positif sur le taux de croissance du marché.

L’augmentation des activités de recherche et développement et l’émergence de nouveaux marchés offriront des opportunités bénéfiques pour le marché du traitement des tumeurs pancréatiques au cours de la période de prévision 2021-2028.

However, high cost of the treatment and complications associated with the disease are the factors that will hinder the market growth. Lack of awareness will further challenge the pancreatic tumor treatment market in the forecast period mentioned above.

This pancreatic tumor  treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pancreatic tumor treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Pancreatic Tumor Treatment Market Scope and Market Size

The pancreatic tumor treatment market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the pancreatic tumor treatment market is segmented into pancreatic exocrine tumors and pancreatic neuroendocrine tumors.
• On the basis of treatment, the pancreatic tumor treatment market is segmented into chemotherapy, targeted therapy, radiation therapy, hormone therapy, palliative care and others.
• On the basis of diagnosis, the pancreatic tumor treatment market is segmented into blood tests, computerized tomography (CT) scan, magnetic resonance imaging (MRI) and others.
• On the basis of dosage, the pancreatic tumor treatment market is segmented into tablet, injection and others.
• On the basis of route of administration, the pancreatic tumor treatment market is segmented into oral, intravenous and others.
• On the basis of end-users, the pancreatic tumor treatment market is segmented into clinic, hospital and others.
• The pancreatic tumor treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Pancreatic Tumor Treatment Market Country Level Analysis

The pancreatic tumour treatment market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel.

The countries covered in the pancreatic tumor treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the pancreatic tumor treatment market due to presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Pancreatic tumor treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Pancreatic Tumor Treatment Market Share Analysis

Pancreatic tumor treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to pancreatic tumor treatment market research.

Certains des principaux acteurs opérant sur le marché du traitement des tumeurs pancréatiques sont Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson Private Limited, Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., Pfizer Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., Sanofi, AbbVie Inc., Amgen Inc., Astellas Pharma Inc., Bayer AG, Takeda Pharmaceutical Company Limited., AstraZeneca et Boehringer Ingelheim International GmbH., entre autres.

SKU-67256